It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Positional coding along the anterior-posterior axis is regulated by HOX genes, whose 3’ to 5’ expression correlates with location along this axis. The precise utilisation of HOX genes in different human cell types is not fully understood. Here, we use single-cell and spatial-transcriptomics, along with in-situ sequencing, to create a developmental atlas of the human fetal spine. We analyse HOX gene expression across cell types during development, finding that neural-crest derivatives unexpectedly retain the anatomical HOX code of their origin while also adopting the code of their destination. This trend is confirmed across multiple organs. In the axial plane of the spinal cord, we find distinct patterns in the ventral and dorsal domains, providing insights into motor pool organisation and loss of collinearity in HOXB genes. Our findings shed new light on HOX gene expression in the developing spine, highlighting a HOX gene ‘source code’ in neural-crest cell derivatives.
The HOX gene cluster is responsible for anteroposterior axis patterning in an evolutionarily conserved manner. Here they examine HOX gene expression in human embryos and show that neural-crest derivatives retain the anatomical HOX code of their origin while also adopting the code of their destination.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details












1 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382); Addenbrooke’s Hospital, Department of Trauma and Orthopaedics, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (GRID:grid.120073.7) (ISNI:0000 0004 0622 5016)
2 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382)
3 Royal National Orthopaedic Hospital, Department of Cellular and Molecular Pathology, Brockley Hill, UK (GRID:grid.416177.2) (ISNI:0000 0004 0417 7890)
4 University College London Great Ormond Street Institute of Child Health, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201)
5 University of Cambridge, Department of Clinical Neurosciences, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934); Puddicombe Way, Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre Cambridge Biomedical Campus, Cambridge, UK (GRID:grid.449973.4) (ISNI:0000 0004 0612 0791)
6 Department of Pathology, University College London (UCL) Cancer Institute, Research, London, UK (GRID:grid.83440.3b) (ISNI:0000 0001 2190 1201)
7 Wellcome Genome Campus, Wellcome Sanger Institute, Hinxton, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382); University of Cambridge, Department of Paediatrics, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000 0001 2188 5934)